CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.17 (-10.18%)
Close on Nov 17, 2026Market cap $22.68MP/E –Yield –
CervoMed price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CervoMed's price to sales ratio was 72.3× on Nov 11, 2026, against 14.9× a year earlier. Over the last 3 years it ranged from 1.9× to 121.3×, with a median of 10.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 72.3× | +60.4 |
| 2025 | Dec 31, 2025 | 11.9× | +9.9 |
| 2024 | Dec 31, 2024 | 1.9× | −7.4 |
| 2023 | Dec 29, 2023 | 9.3× | – |
See a number that looks wrong?